US › Healthcare

Aethlon Medical Inc (AEMD)

US · Healthcare · Medical Devices

$3.52+427.89%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Revenue YoY

-100.0%

Net profit

$-1.9M

Profit YoY

+69.9%

EPS

$-1.20

EPS estimate

$-2.45

EPS came in at -1.20 against a street estimate of -2.45 — a beat of 51.0%.

Key statistics

Market cap

$1.7M

Forward P/E

0.2

P/B

0.36

Book value

$3.11

EPS (TTM)

$-10.61

52-week high

$27.40

52-week low

$0.53

50-day MA

$1.34

200-day MA

$2.56

Beta

1.41

Analyst view

Analysts rate Aethlon Medical Inc a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $3.25.

Shareholding

Insiders

4.17%

Institutions

4.71%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.93%
Ikarian Capital, LLC	0.55%
Shay Capital LLC	0.54%
XTX Topco Ltd	0.51%
Morgan Stanley - Brokerage Accounts	0.08%
Tower Research Capital LLC	0.06%
UBS Group AG	0.03%
Group One Trading, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Aethlon Medical Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.